Stephan M Huber
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 28, 2024
KCa channel targeting impairs DNA repair and invasiveness of patient-derived glioblastoma stem cells in culture and orthotopic mouse xenografts which only in part is predictable by KCa expression levels.Katrin Ganser, Nicolai Stransky, Tayeb Abed
|Nov 23, 2023
Efficacy of combined tumor irradiation and KCa3.1-targeting with TRAM-34 in a syngeneic glioma mouse model.Nicolai Stransky, Katrin Ganser, Leticia Quintanilla-Martinez
|Jan 27, 2022
Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.Katrin Ganser, Franziska Eckert, Andreas Riedel
|Jul 30, 2019
Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice.Sonja Schötterl, Jennifer T Miemietz, Elena I Ilina
|Sep 19, 2018
Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice.Sonja Schötterl, Stephan M Huber, Hans Lentzen
Pageof 1
